Longevity Tech Keeps Conversations Flowing, Life Brokerage CEO Says

Conversation December 31, 2024 at 03:42 PM
Share & Print

37/2b/d94714b04588b8e98fb045b08647/human-biology-shutterstock-mi-640x640-poptika.jpg

One way to help financial services clients think about death, old age and other difficult topics may be to mention related benefits that could help them live longer.

Chad Druvenga, the CEO of CBS Brokerage, a life and annuity brokerage based in Shakopee, Minnesota, said in a recent interview that he and the agents and RIAs that the firm supports are spending a growing amount of time talking about those kinds of longevity tech benefits.

The benefits include the Vitality wellness incentive program at John Hancock and other insurers, moves by several life insurers to offer policyholders free access to Grail's multi-cancer blood screening test, and Hancock's decision to add a discount for full-body MRI screening scans as a perk for some Vitality wellness program members.

When an agent or advisor is talking to clients about the longevity tech benefits, "it almost creates an additional conversation," Druvenga said. "It definitely helps a relationship."

What it means: Life insurers could end up providing a growing market for new longevity tech programs, because clients like hearing about them.

The audience: Druvenga, the new chair-elect of the National Association of Independent Life Brokerage Agencies, an arm of Finseca, said that industry group sessions about the benefits are popular with members.

When financial professionals are talking about the benefits with clients, "the more high-net-worth the client is, the more interested they are in these rewards," Druvenga said.

Uncertainty: One reason the longevity tech programs are perks for life and annuity customers, and not standard parts of checkups, is that regulators and health insurers are still deciding whether the benefits of the programs really outweigh the risk that false alarms may lead some patients to get unnecessary diagnostic tests.

But access to the Grail cancer screening test, for example, "seems to resonate well," even when clients hear about potential drawbacks, and life insurers have been showing their approval by expanding the test access programs, Druvenga said.

Credit: PopTika/Shutterstock

NOT FOR REPRINT

© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Related Stories

Resource Center